Groupama Asset Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$507K Buy
2,144
+63
+3% +$13.1K 0.01% 314
2026
Q1
$440K Sell
2,081
-956
-31% -$206K 0.01% 314
2025
Q4
$624K Sell
3,037
-9,198
-75% -$1.73M 0.01% 307
2025
Q3
$1.92M Sell
12,235
-478
-4% -$73.8K 0.03% 173
2025
Q2
$2.13M Buy
12,713
+409
+3% +$60.7K 0.04% 180
2025
Q1
$1.68M Buy
12,304
+877
+8% +$112K 0.03% 207
2024
Q4
$1.35M Buy
+11,427
New +$1.33M 0.03% 240

Other funds holding CAH

Groupama Asset Management's CAH Position: Q2 2026 in Review

Groupama Asset Management increased its Cardinal Health (CAH) stake by 3% in Q2 2026, buying an estimated $13.1K and bringing the position to 2,144 shares worth $507K. The position accounts for 0.01% of the portfolio, ranked #314.

Groupama Asset Management first reported a position in CAH in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.13M in Q2 2025. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Groupama Asset Management held 2,144 shares of Cardinal Health worth $507K as of Q2 2026.
  • Groupama Asset Management bought 63 Cardinal Health shares in Q2 2026, an estimated $13.1K.
  • Cardinal Health made up 0.01% of Groupama Asset Management's portfolio in Q2 2026, its #314 holding.
  • Groupama Asset Management first reported a position in Cardinal Health in Q4 2024 and has held it in 7 quarters since.
  • Groupama Asset Management's Cardinal Health position peaked at $2.13M in Q2 2025.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.